NSI-189
A small-molecule compound studied for neurogenesis and depression.
Research status: Its Phase 2 depression trial missed its primary endpoint.
This page is a research-orientation summary, not a dosing guide. For anything beyond general background, read the primary literature or talk to a qualified clinician — specifics like amount, frequency, or administration aren't something we publish here.
Related in Cognitive